Your browser doesn't support javascript.
loading
Long-term visual outcomes after ruthenium plaque brachytherapy for posterior choroidal melanoma.
O'Day, Roderick F J; Roelofs, Kelsey A; Negretti, Guy S; Hay, Gordon; Arora, Amit K; Stoker, Ian; Damato, Bertil E; Sagoo, Mandeep S; Cohen, Victoria M L.
Affiliation
  • O'Day RFJ; Ocular Oncology Service, Moorfields Eye Hospital, London, UK. roderick.oday@gmail.com.
  • Roelofs KA; Ocular Oncology Clinic, Royal Victorian Eye and Ear Hospital, Melbourne, Australia. roderick.oday@gmail.com.
  • Negretti GS; Centre for Eye Research Australia, University of Melbourne, Melbourne, Australia. roderick.oday@gmail.com.
  • Hay G; Ocular Oncology Service, Moorfields Eye Hospital, London, UK.
  • Arora AK; Division of Orbital and Ophthalmic Plastic Surgery, Doheny and Stein Eye Institutes, University of California, Los Angeles, USA.
  • Stoker I; Ocular Oncology Service, Moorfields Eye Hospital, London, UK.
  • Damato BE; Ocular Oncology Service, Moorfields Eye Hospital, London, UK.
  • Sagoo MS; NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, UK.
  • Cohen VML; Ocular Oncology Service, Moorfields Eye Hospital, London, UK.
Eye (Lond) ; 37(5): 959-965, 2023 04.
Article in En | MEDLINE | ID: mdl-35140328

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinal Diseases / Ruthenium / Brachytherapy / Choroid Neoplasms / Macular Degeneration / Melanoma Limits: Humans Language: En Journal: Eye (Lond) Journal subject: OFTALMOLOGIA Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinal Diseases / Ruthenium / Brachytherapy / Choroid Neoplasms / Macular Degeneration / Melanoma Limits: Humans Language: En Journal: Eye (Lond) Journal subject: OFTALMOLOGIA Year: 2023 Document type: Article Affiliation country: Country of publication: